pragma.vision Your technology observatory

Verification register Bio, Health & Neuro

Readiness verdict

Lunit INSIGHT CXR / MMG

A dated reading of what is claimed, reported, and independently verified in the current evidence.

As of
2026-06-28
Revision
1
Method
v1.0.0

Current reading

The readiness gap, in one scan

AI-assisted assembly · derived results

Claimed
85

Public ambition and stated capability

Reported
84

Observed practitioner reporting

Verified
76

Independently supported evidence

Gap
+9

Claimed minus verified

Evidence strength Strong

Decision

What the current evidence supports

Human editorial judgment · 2026-06-28

Adopt with guardrails

Why
FDA-cleared (both MMG and CXR), CE-marked in 35+ countries, large training set, peer-reviewed comparative accuracy, independent BreastScreen Norway validation, and real-world deployment data make it the most mature of the three — guardrails needed only because false positives and autonomous-reader regulation remain live constraints.
Next
Scope a concurrent-read (not replacement) pilot integrating INSIGHT MMG/CXR into existing double-reading or triage workflow, with prospective tracking of recall and cancer-detection rates against current baseline.

Constraints

Blockers

No named blocker is present in the current public projection.

Evidence summary

Derived counts

AI-assisted assembly

Total
7
Tier 1
3
Tier 2
1
Tier 3
3
Supports
6
Contradicts
1
Context
0
Latest observed
2026-02-24

Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.

Publication record

Revisions

Initial public reading

This is the initial public reading. No earlier readiness change is recorded.

Your opinion

Tell us anything.

What works, what doesn't, what's missing — especially about our watches, lenses, and the register itself. Anonymous is fine; leave an email if you'd like a reply.